Haemonetics 2nd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website

Rhea-AI Summary

Haemonetics Corporation (NYSE: HAE) releases financial results for Q2 FY2024, available on Investor Relations website, to host conference call and webcast for investors and analysts.

Financial release accessible online

BOSTON, Nov. 2, 2023 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its second quarter fiscal year 2024, which ended September 30, 2023, are available on its Investor Relations website.

The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on November 2, 2023. The conference call and webcast can be accessed with the following information:

• Teleconference link: https://register.vevent.com/register/BI1dcb961b02424b85998e357a476fc7bf 
• Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start.
• A live webcast of the call can be accessed on Haemonetics' investor relations website or via the following link: https://edge.media-server.com/mmc/p/twgnwbaw

In addition, the Company has posted to its Investor Relations website the earnings release that will be referenced on its conference call and webcast, a link to which is available below.  

Direct link to 2Q FY24 Earnings Release:
https://haemonetics.gcs-web.com/static-files/59b19d68-753c-4e39-a6c5-e2ea261b0658

A replay of the conference call and webcast will be available for one year beginning on November 2, 2023, at 11:00 a.m. ET using the conference call webcast link provided in this press release.

ABOUT HAEMONETICS
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.

Investor Contacts:
Olga Guyette, Sr. Director-Investor Relations & Treasury	David Trenk, Manager-Investor Relations
(781) 356-9763	(203) 733-4987
olga.guyette@haemonetics.com	david.trenk@haemonetics.com
Media Contact:
Josh Gitelson, Director-Global Communications
(781) 356-9776
josh.gitelson@haemonetics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-2nd-quarter-fiscal-year-2024-earnings-release-available-on-investor-relations-website-301975313.html

SOURCE Haemonetics Corporation

FAQ

What financial results did Haemonetics Corporation release for Q2 FY2024?

Haemonetics Corporation released its financial results for the second quarter of fiscal year 2024.

Where can the financial results be accessed?

The financial results can be accessed on Haemonetics Corporation's Investor Relations website.

When will the company host a conference call and webcast?

Haemonetics Corporation will host a conference call and webcast to discuss the financial results with investors and analysts.